Characteristic | Study population |
---|---|
(N = 410) | |
Age, years, mean (SD) | 38 (9) |
Female, % | 62 |
No. of relapses in prior study, mean (SD)a | 0.2 (0.5) |
Range | 0–3 |
EDSS score, mean (SD) | 2.7 (1.3) |
Range | 0–6 |
No. of Gd+ lesions, mean (SD) | 0.2 (1.0) |
Range | 0–12 |
Patients with ≥1 Gd+ lesion(s), n (%) | 40 (10) |
No. of T2 hyperintense lesions, mean (SD) | 46.3 (36.5) |
Range | 0–194 |
T2 hyperintense lesion volume, mm3, median | 3868 |
T1 hypointense lesion volume, mm3, median | 751 |
Months on treatment, medianb | 25 |
Range | <1–45 |
Doses, mean (SD) | 27.7 (10.8) |
Median | 28.0 |
Range | 1–49 |